Loading the company…
Loading the company…
Families: Skin substitutes & wound grafts, Bone graft & orthobiologics, Lumbar fusion, Hernia repair.
All companies · Product and company coverage
In the last ten years FDA made 7 decisions for Collagen Matrix (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 4 procedure families, the most in 2024 (3). The latest was on 2024-12-19.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 8 |
| Bone graft & orthobiologics | 7 |
| Lumbar fusion | 7 |
| Hernia repair | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-12-19 | 510(k) | K243071 | Bovine Dermis Collagen Dermal Matrix |
| 2024-10-02 | 510(k) | K242302 | RejuvaKnee Collagen Meniscus Implant |
| 2024-03-12 | 510(k) | K240424 | Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix |
| 2023-08-02 | 510(k) | K231942 | Mineral Collagen Composite Bioactive Extra Moldable |
| 2022-12-20 | 510(k) |
| K221735 |
| Mineral Collagen Composite Bioactive Moldable |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Collagen Matrix.